141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

279573
Tobacco control policy at the national and local levels


Tuesday, November 5, 2013 : 1:10 p.m. - 1:30 p.m.

Ashley Ross, BA, MPH, Center for Tobacco Products, U.S. Food and Drug Administration, US Food and Drug Administration (FDA), Rockville, MD
Joelle Lester, JD, Tobacco Control Legal Consortium, Public Health Law Center, St. Paul, MN
     
This session will help the public health community understand the authority granted in 2009 to the U.S. Food and Drug Administration (FDA) to regulate tobacco, limitations on that authority, and the ways in which federal, state, and local tobacco control efforts can complement each other. FDA staff will address actions taken by the FDA in the first four years of regulating tobacco products and give a sense of future regulatory priorities. Staff from the Tobacco Control Legal Consortium will explain how the public health community can engage in the regulatory process to support the FDA and help it pass tobacco regulations that will have the most significant impact on the public's health. The Consortium will also discuss opportunities for action under the Tobacco Control Act that the FDA has not yet explored. Attendees will learn about specific policy options that they can pursue and understand the different and specific ways in which they can collaborate with and support the FDA's work. At the conclusion of this session, attendees will be able to describe the FDA's role, its activities to date, and the importance of continued state and local tobacco control efforts to support, supplement, and complement the FDA's activities.

Learning Areas:

Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research

Learning Objectives:
Describe the U.S. Food and Drug Administration's authority under the Tobacco Control Act and the steps that the FDA has taken to regulate tobacco products in the 4 years since passage of the Act. Discuss the resources (including the FDA, the Consortium, and other national, state, and local public health professionals) that are available to help the public health community determine where to focus its efforts. Identify action opportunities to support, inform and encourage FDA action on tobacco to promote public health. Evaluate state and local experiences with tobacco control policies to inform and strengthen federal regulation of tobacco products.

Keyword(s): Tobacco, Policy/Policy Development

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I work in the Office of the Center Director at the Food and Drug Administration’s Center for Tobacco Products and is responsible for educating stakeholders about the Tobacco Control Act, working to get them engaged with the agency and identifying ways in which the public health community and the FDA can support each other's tobacco control efforts.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4184.0: The Endgame for Tobacco Control: Strategies and Action Steps